Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

NCT00205816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Tigecycline

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer